These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9121200

  • 1. [Subcutaneous sumatriptan in cluster headache: impossible mission].
    Pascual J, Laínez JM, Alberca R.
    Med Clin (Barc); 1997 Feb 22; 108(7):278-9. PubMed ID: 9121200
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients.
    Rossi P, Lorenzo GD, Formisano R, Buzzi MG.
    Headache; 2004 Feb 22; 44(7):713-8. PubMed ID: 15209695
    [Abstract] [Full Text] [Related]

  • 7. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan.
    Gregor N, Schlesiger C, Akova-Oztürk E, Kraemer C, Husstedt IW, Evers S.
    Headache; 2005 Sep 22; 45(8):1069-72. PubMed ID: 16109122
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan.
    Pascual J, Quijano J.
    J Neurol Neurosurg Psychiatry; 1998 Sep 22; 65(3):407. PubMed ID: 9728969
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cluster headache: symptomatic treatment.
    Torelli P, Manzoni GC.
    Neurol Sci; 2004 Oct 22; 25 Suppl 3():S119-22. PubMed ID: 15549518
    [Abstract] [Full Text] [Related]

  • 14. [Use of triptanes according to indications. Risk of infarct is not increased].
    MMW Fortschr Med; 2004 Feb 12; 146(7):60. PubMed ID: 15347059
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P, Vakaet A, Monseu G, Jacquy J, Bourgeois P, van der Linden C.
    Acta Neurol Belg; 1998 Dec 12; 98(4):332-41. PubMed ID: 9922821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Trigeminal autonomic cephalgias: diagnostic and therapeutic implications].
    Rosenberg-Nordmann M, Tölle TR, Sprenger T.
    MMW Fortschr Med; 2007 Sep 06; 149(35-36):39-41. PubMed ID: 17944284
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Patient information regarding subcutaneous self-administration of sumatriptan (imitrex).
    Rothrock JF.
    Headache; 2007 Apr 06; 47(4):639. PubMed ID: 17445120
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.